When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now,…
SAN DIEGO — I’m not a doctor. I’m not a scientist. I barely made it through my math and science classes in college. Actually,…
SAN DIEGO — The scientific data was virtually unreadable, the explanations often too complex for the layman or woman to understand. But there was…
SAN DIEGO — A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions and…
SAN DIEGO — A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions. ACADIA…
The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Reporting on a procedure performed last year, scientists at the West Virginia University Rockefeller Neuroscience Institute said today that using low-intensity focused ultrasound is…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us